Autolus Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $21,194 | $20,923 | $8,982 | $29 |
Gross Profit | -7,449 | -3,522 | -8,969 | -138,275 |
EBITDA | -64,703 | -56,906 | -55,516 | -73,787 |
EBIT | -68,066 | -61,217 | -57,793 | -75,864 |
Net Income | -79,118 | -47,917 | -70,161 | -27,606 |
Net Change In Cash | 21,194 | 20,923 | 8,982 | 29 |
Free Cash Flow | -52,379 | -80,058 | -83,808 | -61,790 |
Cash | 86,124 | 123,825 | 95,799 | 227,380 |
Basic Shares | 266,141 | 266,141 | 266,126 | 266,125 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $10,120 | $1,698 | $6,194 | $1,507 |
Gross Profit | -130,900 | 1,698 | 6,194 | 1,507 |
EBITDA | -233,073 | -156,770 | -132,240 | -132,475 |
EBIT | -240,789 | -163,335 | -139,662 | -140,933 |
Net Income | -220,662 | -208,383 | -148,839 | -142,096 |
Net Change In Cash | 10,120 | 1,698 | 6,194 | 1,507 |
Free Cash Flow | -241,090 | -156,573 | -123,149 | -126,718 |
Cash | 227,380 | 239,566 | 382,436 | 310,338 |
Basic Shares | 255,161 | 173,941 | 94,993 | 72,084 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.30 |
2025-06-30 | -$0.18 |
2025-03-31 | -$0.26 |
2024-12-31 | -$0.09 |
